Enterovirus Genotype EV-104 in Humans, Italy, 2008–2009
Figure 2. Virologic and clinical follow-up of immunocompromised patient infected with Pavia strain (Pav-5) showing the kinetics of enterovirus 104 (EV-104) and respiratory syncytial virus (RSV) viral loads, along with respiratory symptoms. Starting on day 90 after transplantation, the patient’s clinical symptoms began to disappear in the presence of a substantially unchanged EV-104 viral load in respiratory secretions. Ct, cycle threshold; HSC, hematopoietic stem cells.